The researchers — led by Spyros Kitsiou, a biomedical and health information sciences researcher at University of Illinois at Chicago — identified 15 systematic reviews related to mHealth interventions and diabetes management. From these reviews, the researchers extracted data about health outcomes.
They found that for patients with Type 2 diabetes, mobile health interventions improved glycemic control by as much as 0.8 percent when compared to other non-mHealth approaches. For patients with Type 1 diabetes, mobile health interventions improved glycemic control as much as 0.3 percent.
“Findings are consistent with clinically relevant improvements, particularly with respect to patients with Type 2 diabetes,” the researchers concluded. “Similar to home telemonitoring, mHealth interventions represent a promising approach for self-management of diabetes.”
More articles on health IT:
Office of Inspector General: 9 findings on HHS compliance with IT security
DOD awards $1.2M to study mHealth, diabetes
10 digital health startups to compete at SXSW’s Impact Pediatric Health
